Design, synthesis and characterisation of new chimeric ruthenium(ii)–gold(i) complexes as improved cytotoxic agents

Gold(i) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents

(2015) Tatiyana V. Serebryanskaya et al.   DALTON TRANSACTIONS

New heteronuclear gold(I)–platinum(II) complexes with cytotoxic properties: Are two metals better than one?

(2014) Margot Wenzel et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer

(2014) Malgorzata Frik et al.   JOURNAL OF MEDICINAL CHEMISTRY

Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties

(2014) Jacob Fernández-Gallardo et al.   ORGANOMETALLICS

In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas

(2014) Andrea Weiss et al.   Chemical Science

Luminescent Re(i) and Re(i)/Au(i) complexes as cooperative partners in cell imaging and cancer therapy

(2014) Vanesa Fernández-Moreira et al.   Chemical Science

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity

(2014) Zenita Adhireksan et al.   Nature Communications

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds

(2013) Benoît Bertrand et al.   DALTON TRANSACTIONS

Efficient and Rapid Synthesis of Chlorido-Bridged Half-Sandwich Complexes of Ruthenium, Rhodium, and Iridium by Microwave Heating

(2013) Justus Tönnemann et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Potential Anticancer Heterometallic Fe–Au and Fe–Pd Agents: Initial Mechanistic Insights

(2013) Nicholas Lease et al.   JOURNAL OF MEDICINAL CHEMISTRY

Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications

(2013) Alexey A. Nazarov et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

A Chloro-Bridged Heterobimetallic (η6-Arene)ruthenium–Organotin Complex as an Efficient Topoisomerase Iα Inhibitor

(2013) Rais Ahmad Khan et al.   ORGANOMETALLICS

[RuCl2(η6-p-cymene)(P*)] and [RuCl2(κ-P*-η6-arene)] Complexes Containing P-Stereogenic Phosphines. Activity in Transfer Hydrogenation and Interactions with DNA

(2013) Rosario Aznar et al.   ORGANOMETALLICS

A dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo

(2013) Raymond Wai-Yin Sun et al.   Chemical Science

WinGXandORTEP for Windows: an update

(2012) Louis J. Farrugia   JOURNAL OF APPLIED CRYSTALLOGRAPHY

Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme

(2012) Chiara Gabbiani et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Synthesis, Characterization, and in Vitro Studies of Bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) Complexes

(2012) Wukun Liu et al.   JOURNAL OF MEDICINAL CHEMISTRY

Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents

(2012) Esther Schuh et al.   JOURNAL OF MEDICINAL CHEMISTRY

Platinum(II) and gold(I) complexes based on 1,1′-bis(diphenylphosphino)metallocene derivatives: Synthesis, characterization and biological activity of the gold complexes

(2012) Haris Bjelosevic et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Titanocene–Phosphine Derivatives as Precursors to Cytotoxic Heterometallic TiAu2and TiM (M = Pd, Pt) Compounds. Studies of Their Interactions with DNA

(2011) Jose F. González-Pantoja et al.   INORGANIC CHEMISTRY

Multinuclear Cytotoxic Metallodrugs: Physicochemical Characterization and Biological Properties of Novel Heteronuclear Gold–Titanium Complexes

(2011) Margot Wenzel et al.   INORGANIC CHEMISTRY

Approaching tumour therapy beyond platinum drugs

(2011) A. Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Gold compounds as therapeutic agents for human diseases

(2011) Susan J. Berners-Price et al.   Metallomics

Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties

(2010) Frédéric Pelletier et al.   JOURNAL OF MEDICINAL CHEMISTRY

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

(2009) Alberto Bindoli et al.   COORDINATION CHEMISTRY REVIEWS

Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action

(2009) Sangeeta Das et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model

(2009) A. Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)−Arene Compounds

(2008) Angela Casini et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and characterization of RuII/AuI, PdII/AuI, PdII/2AuI, PtII/2AuI and CuI/2AuI heterometallic complexes of cyclodiphosphazane cis-{(o-MeOC6H4O)P(μ-NtBu)}2

(2007) P. Chandrasekaran et al.   POLYHEDRON